<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00180791</url>
  </required_header>
  <id_info>
    <org_study_id>PNET HR</org_study_id>
    <nct_id>NCT00180791</nct_id>
  </id_info>
  <brief_title>High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood</brief_title>
  <official_title>Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gustave Roussy, Cancer Campus, Grand Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gustave Roussy, Cancer Campus, Grand Paris</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of the combination of surgery,
      conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell
      transplantation and reduced dose radiation therapy in high-risk PNET brain tumors.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2002</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response of medulloblastoma metastases to the chemotherapy regimen in children less than 5 years of age</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-free survival of children less than 10 years of age with brain PNET</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival of children less than 5 years of age with metastatic medulloblastoma</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term sequelae</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">71</enrollment>
  <condition>Medulloblastoma</condition>
  <condition>Brain Tumors</condition>
  <condition>Neuroectodermal Tumors, Primitive</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etoposide, carboplatin, melphalan, cisplatin, thiotepa</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medulloblastoma in patients less than 5 years of age

          -  Brain PNET in patients less than 10 years of age

          -  Histologically documented diagnosis

          -  Body weight of &gt; 8 kg

        Exclusion Criteria:

          -  Parents' refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chantal Kalifa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gustave Roussy, Cancer Campus, Grand Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chantal Kalifa, MD</last_name>
    <phone>33 1 42 11 4166</phone>
    <email>kalifa@igr.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Agn√®s Laplanche, MD</last_name>
    <phone>33 1 42 11 4127</phone>
    <email>laplanche@igr.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Kalifa, MD</last_name>
      <phone>33 1 42 11 4166</phone>
      <email>kalifa@igr.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>September 17, 2007</last_update_submitted>
  <last_update_submitted_qc>September 17, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2007</last_update_posted>
  <keyword>Brain PNET</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Medulloblastoma</mesh_term>
    <mesh_term>Neuroectodermal Tumors</mesh_term>
    <mesh_term>Neuroectodermal Tumors, Primitive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Melphalan</mesh_term>
    <mesh_term>Thiotepa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

